Jos Weusten

947 total citations
31 papers, 705 citations indexed

About

Jos Weusten is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, Jos Weusten has authored 31 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Pharmacology. Recurrent topics in Jos Weusten's work include Hormonal and reproductive studies (7 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Hepatitis B Virus Studies (3 papers). Jos Weusten is often cited by papers focused on Hormonal and reproductive studies (7 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Hepatitis B Virus Studies (3 papers). Jos Weusten collaborates with scholars based in Netherlands, United States and Spain. Jos Weusten's co-authors include Marion Vermeulen, Harry van Drimmelen, Nico Lelie, A. G. H. Smals, P.N. Lelie, J. Herbergs, Henk‐Jan Schuurman, F.H.J. Gmelig-Meyling, J.H.H. Thijssen and Marinus A. Blankenstein and has published in prestigious journals such as Nucleic Acids Research, The Journal of Clinical Endocrinology & Metabolism and Endocrinology.

In The Last Decade

Jos Weusten

30 papers receiving 665 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jos Weusten Netherlands 15 206 170 140 128 100 31 705
Chunling Li China 17 94 0.5× 296 1.7× 23 0.2× 29 0.2× 113 1.1× 39 695
Michael Cooreman United States 13 417 2.0× 254 1.5× 364 2.6× 41 0.3× 72 0.7× 23 910
George Tang United States 14 140 0.7× 256 1.5× 86 0.6× 141 1.1× 27 0.3× 39 837
Yunlong Li China 16 119 0.6× 254 1.5× 172 1.2× 34 0.3× 145 1.4× 85 791
Masakazu Kakuni Japan 15 165 0.8× 256 1.5× 175 1.3× 23 0.2× 39 0.4× 31 674
Shirish Paranjpe United States 19 284 1.4× 254 1.5× 454 3.2× 24 0.2× 139 1.4× 30 963
Michelle Skelton South Africa 13 68 0.3× 202 1.2× 43 0.3× 32 0.3× 120 1.2× 33 638

Countries citing papers authored by Jos Weusten

Since Specialization
Citations

This map shows the geographic impact of Jos Weusten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jos Weusten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jos Weusten more than expected).

Fields of papers citing papers by Jos Weusten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jos Weusten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jos Weusten. The network helps show where Jos Weusten may publish in the future.

Co-authorship network of co-authors of Jos Weusten

This figure shows the co-authorship network connecting the top 25 collaborators of Jos Weusten. A scholar is included among the top collaborators of Jos Weusten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jos Weusten. Jos Weusten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Jian, Sandra M.H. Claessen, Jos Weusten, et al.. (2017). The idiosyncratic drug-induced gene expression changes in HepG2 cells. Data in Brief. 14. 462–468. 1 indexed citations
3.
Weusten, Jos, et al.. (2016). Process capability in industry: Setting preliminary statistical specification limits. Quality Engineering. 29(4). 713–718. 3 indexed citations
4.
Weusten, Jos, et al.. (2015). Studies on the Application of Filter‐Based IR Detector for Polyolefin Characterization with HT‐SEC. Macromolecular Symposia. 356(1). 87–94. 12 indexed citations
5.
Mommers, John, et al.. (2013). Quantitative analysis of morphine in dried blood spots by using morphine-d3 pre-impregnated dried blood spot cards. Analytica Chimica Acta. 774. 26–32. 19 indexed citations
6.
Weusten, Jos, E.P.P.A. Derks, John Mommers, & Sjoerd van der Wal. (2012). Alignment and clustering strategies for GC×GC–MS features using a cylindrical mapping. Analytica Chimica Acta. 726. 9–21. 15 indexed citations
7.
Weusten, Jos & J. Herbergs. (2011). A stochastic model of the processes in PCR based amplification of STR DNA in forensic applications. Forensic Science International Genetics. 6(1). 17–25. 42 indexed citations
8.
Weusten, Jos, Marion Vermeulen, Harry van Drimmelen, & Nico Lelie. (2010). Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms. Transfusion. 51(1). 203–215. 101 indexed citations
9.
Weusten, Jos. (2008). A statistical approach to assess analytical sensitivity of diagnostic assays in the presence of false-positive results. Journal of Virological Methods. 151(2). 308–310. 3 indexed citations
10.
Weusten, Jos, et al.. (2002). Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window‐phase donations not detected by NAT. Transfusion. 42(5). 537–548. 85 indexed citations
11.
Weusten, Jos. (2002). Stochastic processes defining sensitivity and variability of internally calibrated quantitative NASBA-based viral load assays. Nucleic Acids Research. 30(24). 137e–137. 7 indexed citations
13.
Beuningen, Rinie van, et al.. (2001). <title>Development of a high-throughput detection system for HIV-1 using real-time NASBA based on molecular beacons</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 4264. 66–71. 12 indexed citations
14.
Oei, S. Guid, Jan Derksen, Jos Weusten, Eef G.W.M. Lentjes, & Frans M. Helmerhorst. (1995). A case of 16-ene-synthetase deficiency in male pseudohermaphroditism due to combined 17α-hydroxylase/17,20-lyase deficiency. European Journal of Endocrinology. 132(3). 281–285. 5 indexed citations
15.
Smals, A. G. H., Jos Weusten, & Theo J. Benraad. (1991). The HMG-CoA reductase inhibitor simvastatin suppresses human testicular testosterone synthesis in vitro by a selective inhibitory effect on 17-ketosteroid-oxidoreductase enzyme activity. The Journal of Steroid Biochemistry and Molecular Biology. 38(4). 465–468. 39 indexed citations
16.
Weusten, Jos, et al.. (1990). Differential Metabolism of Pregnenolone by Testicular Homogenates of Humans and Two Species of Macaques. Hormone and Metabolic Research. 22(12). 619–621. 3 indexed citations
17.
Noteborn, H.P.J.M., Jos Weusten, Hella Bartsch, et al.. (1989). Partial Purification of a Polypeptide Extract Derived From Ovine Pineal That Suppresses the Growth of Human Melanoma Cells In Vitro. Journal of Pineal Research. 6(4). 385–396. 3 indexed citations
18.
Weusten, Jos, et al.. (1989). The mechanism of the synthesis of 16-androstenes in human testicular homogenates. Journal of Steroid Biochemistry. 32(5). 689–694. 37 indexed citations
19.
Noteborn, H.P.J.M., Hella Bartsch, Christian Bartsch, et al.. (1988). Partial purification of (a) low molecular weight ovine pineal compound(s) with an inhibiting effect on the growth of human melanoma cells in vitro. Journal of Neural Transmission. 73(2). 135–155. 16 indexed citations
20.
Weusten, Jos, A. G. H. Smals, J Hofman, P. W. C. Kloppenborg, & Th. J. Benraad. (1987). The Sex Pheromone Precursor Androsta-5,16-dien-3β-ol Is a Major Early Metabolite inin VitroPregnenolone Metabolism in Human Testicular Homogenates. The Journal of Clinical Endocrinology & Metabolism. 65(4). 753–756. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026